MicroRNA Research Trends 2009 Market ReportSelect Biosciences LimitedJuly 1, 2009 134 Pages - SKU: SBS2435628 |
|
Outsourcing in Drug Discovery: The Contract Research Organization (CRO) Market, 5th Edition
5/11/2012 | published by: Kalorama Information
The drug discovery process is long, arduous and costly, which has driven outsourcing in this field. The first phase is discovery of a lead compound, a molecule that affects biological function by binding to a
|
more...
|
$3,995.00
|
|
The Worldwide Market for In Vitro Diagnostic Tests, 8th Edition (pre-publication)
7/20/2012 | published by: Kalorama Information
ESTIMATED AVAILABILITY: JULY 20TH, 2012
|
more...
|
$6,500.00
|
|
Clinical Lab Services Market (Growth Opportunities, Competitive Analysis and Competitor Profiles)
4/30/2012 | published by: Kalorama Information
Since the last time Kalorama Information studied the market for clinical lab services two years ago, there have been substantial changes in the industry, including changes in market share as major companies eat into regional
|
more...
|
$3,500.00
|
|
In Vitro Diagnostics - A Global Market Overview
5/14/2012 | published by: Industry Experts
`The In Vitro Diagnostic (IVD) industry has been confronting a range of issues, such as regulations, industry consolidation, reforms in healthcare, low level of technological innovations and ever-changing demographics. Though some of these challenges may
|
more...
|
$4,500.00
|
|
In Vitro Diagnostics (IVD) - Emerging Countries (Brazil, Russia, India, China) Opportunity Assessment, Competitive Landscape and Market Forecasts to 2018
5/8/2012 | published by: GlobalData
In Vitro Diagnostics (IVD) - Emerging Countries (Brazil, Russia, India, China) Opportunity Assessment, Competitive Landscape and Market Forecasts to 2018 Summary GlobalData’s new report, “In Vitro Diagnostics (IVD) - Emerging Countries (Brazil, Russia, India, China) Opportunity Assessment,
|
more...
|
$3,995.00
|
|
541711 Research and Development In Biotechnology: State Industry Market Evaluator
6/1/2012 | published by: BizMiner
This State Industry Market Evaluator reports on industry trends broken out for each US state. Each state sub-report is comprised of eight pages of data. Statistics are displayed for 2008-2009-2010 and 2011q2 for these measures:
|
more...
|
$699.00
|
|
IVD Market Research Bundle (In Vitro Diagnostic Test Markets, BRIC and Other Regional Markets, Biomarker Testing and Other Pharmacodiagnostics)
3/3/2012 | published by: Kalorama Information
What does the diagnostic market look like today, how is the continuing economic news effecting the market, and what are companies doing right now to prosper? This diagnostic industry market research bundle, with over
|
more...
|
$5,995.00
|
|
World Market for Prescription Dermatological Drugs, 8th Edition (Antiacne, Antiaging, Dermatitis, Hair Loss, Psoriasis, Skin Cancer, Melasma and Seborrhea Treatments)
3/1/2012 | published by: Kalorama Information
This Kalorama Information report, The Worldwide Market for Prescription Dermatological Drugs represents the eighth time that Kalorama has detailed the various categories of prescription dermatological drugs, describing the global market and identifying major market factors
|
more...
|
$3,995.00
|
|
World Market for Personalized Medicine Diagnostics (Biomarkers, Pharmacodiagnostics, Tumor Assays, Cardiac Risk and Other Testing)
3/1/2012 | published by: Kalorama Information
In this market research report, Kalorama Information defines the current opportunity and a realistic future potential for personalized medicine in clinical testing. In addition to analysis of tests currently on the market and in development,
|
more...
|
$3,795.00
|
|
Triple Analysis: Angiogenesis, Protein Kinase Inhibitors and Peptides
5/1/2012 | published by: BioSeeker Group AB
This triple analysis focuses on cancer drug development strategies by the two mechanism/target/effect areas of Angiogenesis and Protein Kinase Inhibitors and by the compound strategy of Peptides. Each of these three individual parts is evaluated
|
more...
|
$5,175.00
|
Related Markets
- Biotechnology
- Genomics
- Research & Development
- Diseases & Conditions
- Alzheimer's Disease
- In Vitro Diagnostics
- General In Vitro Diagnostics
- Therapeutic Area
- CNS/Neurology
- Oncology/Hematology
Oncology/Hematology Reports
- Triple Analysis: Lymphoma, Protein Kinase Inhibitors and Antibodies
- Triple Analysis: Leukemia, Protein Kinase Inhibitors and Antibodies
- Triple Analysis: Breast Cancer, Protein Kinase Inhibitors and Antibodies
- Commercializing Biomarkers in Therapeutic and Diagnostic Applications
- Hematological Cancer Therapies
